Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUNIC, INC. Director's Dealing 2021

Aug 11, 2021

10196_dirs_2021-08-11_99b51272-9062-4053-87d5-52666c37c755.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2021-08-10

Reporting Person: Vitt Daniel (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-10 Common Stock P 1000 $9.60 Acquired 363877 Indirect

Footnotes

F1: 1,000 shares are owned directly by the Reporting Person and 362,877 shares are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares.